You are here: All Products  > Takeda Signs $100 Million Option for Ascentage’s Lead TKI Therapy

Takeda Signs $100 Million Option for Ascentage’s Lead TKI Therapy

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days. 


Back to products